ZNF807P

Across TCGA pan-cancer cohorts, ZNF807P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ZNF807P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where ZNF807P RNA is repressed in tumor relative to normal tissue. In most cancer types ZNF807P is over-expressed in tumor, although a few such as UCEC and BRCA show the opposite, repressed pattern.

UCEC, BRCA, and LUSC are the cancer types where ZNF807P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF807P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.128	<.001	6	view →
BRCA	Female	II,III,IV	−0.074	.007	4	view →
LUSC	Female	II,III,IV	−0.081	.022	2	view →
PRAD	All	All	+0.065	.040	2	view →
THCA	All	IV	−0.242	.013	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

ZNF807P–UCEC

Open the UCEC breakdown →